Volume 18, Number 7—July 2012
Research
Validity of International Health Regulations in Reporting Emerging Infectious Diseases
Michael Edelstein
, David L. Heymann, Johan Giesecke, and Julius Weinberg
, David L. Heymann, Johan Giesecke, and Julius WeinbergTable 2
Characteristics of 175 EID events reported to WHO*
| Characteristic | No. (%) |
|---|---|
| Type of pathogen | |
| Bacterium | 89 (50.9) |
| Virus | 39 (22.3) |
| Rickettsia | 12 (6.9) |
| Protozoan | 20 (11.4) |
| Helminth | 2 (1.1) |
| Fungus | 12 (6.9) |
| Prion | 1 (0.6) |
| WHO region | |
| AMRO | 77 (44.0) |
| EURO | 49 (28.0) |
| EMRO | 7 (4.0) |
| SEARO | 10 (5.7) |
| WPRO | 24 (13.7) |
| AFRO | 8 (4.6) |
| Type of event | |
| New pathogen | 70 (40.0) |
| Increased incidence | 44 (25.1) |
| Antimicrobial drug resistance | 54 (30.9) |
| New clinical manifestation | 7 (4.0) |
*EID, emerging infectious disease; WHO, World Health Organization; AMRO, Americas; EURO, Europe; EMRO, Eastern Mediterranean; SEARO, Southeast Asia; WPRO, Western Pacific; AFRO, Africa.
